- Sentiment on Asian markets remains positive following yesterday's gains on Wall Street. Markets in China, Australia, and New Zealand are gaining value, while the Japanese Nikkei 225 index is down 1%.
- Before the opening of the cash session in Europe, the EU50 contract is up 0.12%.
- Today, we saw good Caixin PMI data for industry in China, which unexpectedly broke above the 50 barrier, signaling growth in this sector. Caixin PMI for June 2025 for industry 50.4 (forecast 49.0, previously 48.3).
- The dispute between Donald Trump and Elon Musk continues. Trump says that perhaps DOGE should “take a close look” at Elon and the subsidies his companies receive. Tesla shares are down 6% ahead of the Wall Street opening.
- According to the Financial Times, US officials working on the tariff changes are reportedly seeking to conclude more modest trade agreements before the July 9 deadline. More modest and narrower trade agreements are in stark contrast to the 90 agreements in 90 days that they had been aiming for.
- The European Central Bank's annual forum in Sintra is still ongoing. Today, we will hear statements from Andrew Bailey (BoE), Christine Lagarde (ECB), Jerome Powell (FED) and Kazuo Ueda (BoJ). 3:30 p.m CEST.
- The USD/JPY fell below 143.60 after the Bank of Japan released its Tankan report, which showed higher-than-expected activity in the industrial sector (13 points vs. 10 points expected).
- The US dollar lost value at the beginning of the session, but has since rebounded slightly. The EUR/USD exchange rate rose, briefly reaching above 1.1800.
- This morning is particularly favorable for gold prices, which are up 0.82% to $3,329 per ounce. GOLD is back above the 50-day EMA.
- The macro calendar will focus today on PMI data for industry from the world's major economies. At 11:00 a.m., we will also see CPI data from the eurozone and JOLTS data from the US (4:00 p.m.). We will also hear the aforementioned numerous speeches by central bankers. All CEST time.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
